InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Renger John, Directeur Scientifique. Insider active across 1 company, notably Cerevel Therapeutics Holdings, Inc.. Cumulatively, 18 filings have been recorded. History available since 10 November 2021. The latest transaction was filed on 1 November 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Renger John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
6,370 sharesCommon StockSEC:0000950170-24-090830:0
5,020 sharesCommon StockSEC:0000950170-24-012962:0
10,018 shares@ US$3.502.3% of flowCommon StockSEC:0000899243-22-034915:0
10,018 shares@ US$3.502.2% of flowCommon StockSEC:0000899243-22-033167:0
29,624 shares@ US$3.506.4% of flowCommon StockSEC:0000899243-22-028481:0
20,000 shares@ US$3.504.4% of flowCommon StockSEC:0000899243-22-028190:0
25,000 shares@ US$3.505.5% of flowCommon StockSEC:0000899243-22-026577:0
25,000 shares@ US$3.505.5% of flowCommon StockSEC:0000899243-22-025685:0
45,000 shares@ US$3.5012.0% of flowCommon StockSEC:0000899243-22-014882:0
10,000 shares@ US$3.502.6% of flowCommon StockSEC:0000899243-22-012940:0
25,000 shares@ US$3.506.6% of flowCommon StockSEC:0000899243-22-011639:0
30,000 shares@ US$3.508.0% of flowCommon StockSEC:0000899243-22-010697:0
25,000 shares@ US$3.506.5% of flowCommon StockSEC:0000899243-22-009392:0
25,000 shares@ US$3.506.4% of flowCommon StockSEC:0000899243-22-005941:0
5,873 shares@ US$3.501.5% of flowCommon StockSEC:0000899243-21-049933:0
7,300 shares@ US$3.501.9% of flowCommon StockSEC:0000899243-21-049620:0
25,000 shares@ US$3.506.5% of flowCommon StockSEC:0000899243-21-048894:0
55,000 shares@ US$3.5013.8% of flowCommon StockSEC:0000899243-21-044579:0
18 of 18 declarations
About Renger John
Renger John is Directeur Scientifique and Chief Scientific Officer at Cerevel Therapeutics Holdings, Inc. The 18 filings recorded, all within the recent sampled filings held, cover the period from November 15, 2021 to August 5, 2024, with the transaction nature listed as option exercise.
